PGH
HZNP

Partners Group Holding’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Partners Group Holding’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-82,010
Closed -$1.01M – 49
2014
Q3 		$1.01M Buy
+82,010
New +$953K 0.22% 35

Other funds holding HZNP

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Partners Group Holding's HZNP Position: Q4 2014 in Review

Partners Group Holding sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2014, closing a stake of 82,010 shares — an estimated $1.01M sold.

Partners Group Holding first reported a position in HZNP in Q3 2014 and held it in 1 quarter. The position peaked at $1.01M in Q3 2014. 136 funds tracked by Wall St. Rank hold HZNP as of Q4 2014.

  • Partners Group Holding reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2014 after selling out during the quarter.
  • Partners Group Holding sold 82,010 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2014, an estimated $1.01M.
  • Partners Group Holding first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 1 quarter.
  • Partners Group Holding's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.01M in Q3 2014.
  • 136 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2014.

Based on Partners Group Holding's 13F filing for Q4 2014, filed 10 Feb 2015.